Home › Funds › Two Sigma Investments › PRLD
Two Sigma Investments position in PRLD
PRELUDE THERAPEUTICS INC · Health Care
Latest position (Q2 2026)993.37K sh
Reported value held$5.29M
Portfolio Weight0.00%
First reportedQ4 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 282.77K | $3.52M | New |
| Q1 2022 | 180.41K | $1.25M | Reduce |
| Q2 2022 | 223.84K | $1.17M | Add |
| Q3 2022 | 105.60K | $698.00K | Reduce |
| Q4 2022 | 51.90K | $313.46K | Reduce |
| Q1 2023 | 22.45K | $127.99K | Reduce |
| Q2 2023 | 39.29K | $176.81K | Add |
| Q3 2023 | 12.81K | $39.59K | Reduce |
| Q4 2023 | 58.28K | $248.87K | Add |
| Q1 2024 | 60.60K | $287.23K | Add |
| Q2 2024 | 43.13K | $164.34K | Reduce |
| Q3 2024 | 56.93K | $117.85K | Add |
| Q4 2024 | 231.84K | $295.60K | Add |
| Q1 2025 | 183.67K | $141.06K | Reduce |
| Q1 2025 | 183.67K | $141.06K | Reduce |
| Q2 2025 | 154.98K | $125.44K | Reduce |
| Q2 2025 | 154.98K | $125.44K | Reduce |
| Q3 2025 | 152.23K | $219.22K | Reduce |
| Q4 2025 | 788.70K | $2.29M | Add |
| Q1 2026 | 923.63K | $3.16M | Add |
| Q2 2026 | 993.37K | $5.29M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding PRLD
- BlackRock Inc 1.80M sh · $9.58M · Q2 2026
- Millennium Management 844.99K sh · $4.50M · Q2 2026
- Geode Capital Management 841.86K sh · $4.49M · Q2 2026
- Vanguard Group 1.41M sh · $4.10M · Q4 2025
- Morgan Stanley 503.86K sh · $2.69M · Q2 2026
- UBS Group AG 318.80K sh · $1.70M · Q2 2026
- Renaissance Technologies 281.20K sh · $1.50M · Q2 2026
- Northern Trust Corp 240.60K sh · $1.28M · Q2 2026
- Marshall Wace 190.69K sh · $1.02M · Q2 2026
- Goldman Sachs Group 120.83K sh · $644.04K · Q2 2026
- BNY Mellon 68.19K sh · $363.44K · Q2 2026